Recombinant Borrelia recurrentis Serine hydroxymethyltransferase (glyA)

What is Borrelia recurrentis and why is it significant for glyA research?

Borrelia recurrentis is the causative agent of louse-borne relapsing fever (LBRF), a deadly though treatable disease endemic in the Horn of Africa with epidemic potential. Research on B. recurrentis has been historically hampered due to limitations in animal models, as successful infection was previously only achieved in primates . B. recurrentis represents a uniquely adapted pathogen that appears to have evolved from B. duttonii through genome reduction and loss of certain DNA repair mechanisms, making its enzymes and metabolic pathways particularly interesting for comparative genomic studies . The glyA gene encoding serine hydroxymethyltransferase is of particular interest due to its central role in one-carbon metabolism in bacteria .

How does the genome of B. recurrentis compare to related Borrelia species?

B. recurrentis exhibits approximately 20.4% genome size reduction compared to B. duttonii, with B. recurrentis appearing to be a strain of B. duttonii with a decaying genome . This genomic decay is likely due to the accumulation of errors resulting from the loss of DNA repair mechanisms, specifically recA and mutS genes . Genome analysis shows that B. recurrentis has 800 protein-coding genes on its chromosome compared to 820 in B. duttonii . Several genes are duplicated in B. recurrentis, including recJ, with one copy containing a frameshift . The genome content is characterized by several repeat families, including antigenic lipoproteins, but with reduced coding capacity, including fewer surface-exposed lipoproteins and putative virulence factors compared to B. duttonii .

What is the role of serine hydroxymethyltransferase in bacterial metabolism?

Serine hydroxymethyltransferase (SHMT) occupies a central position in bacterial one-carbon metabolism . Based on studies in Corynebacterium glutamicum, SHMT activity increases approximately 3-fold during exponential growth with a further increase at the onset of the stationary phase . The enzyme catalyzes the reversible conversion of serine and tetrahydrofolate to glycine and 5,10-methylenetetrahydrofolate, providing one-carbon units essential for the biosynthesis of purines, thymidylate, methionine, and other metabolites . In many bacteria, the glyA gene is transcribed as a monocistronic mRNA and its expression can be controlled by specific regulatory proteins .

How can the role of phagocytic cells be investigated in relation to B. recurrentis infection?

Phagocytic cells play a critical role in controlling B. recurrentis infection. This can be investigated by systemic depletion of phagocytic cells in experimental mice using clodronate liposomes . Studies have shown that such depletion results in a one-hundred-fold increase in B. recurrentis titers in blood . This experimental approach highlights the importance of macrophages and other phagocytes in controlling relapsing fever infection and could be adapted to study how these immune cells interact with specific B. recurrentis proteins, including those involved in metabolic pathways like SHMT .

What serological methods can be used to detect B. recurrentis proteins?

Several serological methods have been validated for B. recurrentis, which could be adapted for detecting recombinant proteins. These include:

• Indirect Immunofluorescence Assay (IFA): Using whole cells of B. recurrentis as antigens, this method has shown geometric mean titers of 1:83 and 1:575 for acute- and convalescent-phase serum samples, respectively .

• Enzyme-Linked Immunosorbent Assay (ELISA): Can be performed using whole-cell lysates or purified recombinant proteins .

• Immunoblotting: Western blot analysis using whole-cell lysates of the spirochete or E. coli expressing recombinant proteins has shown high sensitivity in detecting antibody responses . For semi-quantitative analysis, the thickness of reactive bands can be measured with a transmission dissecting microscope fitted with a calibrated ocular micrometer .

How might the genetic decay in B. recurrentis affect glyA expression and function?

B. recurrentis has undergone significant genome reduction and shows evidence of genetic decay compared to B. duttonii, likely due to the loss of DNA repair mechanisms including recA and mutS . The recA gene in B. recurrentis contains a frameshift mutation that renders it non-functional . This genetic deterioration raises important questions about how essential metabolic genes like glyA might be affected.

Research approaches to investigate this could include:

• Comparative genomic analysis of the glyA sequence and its regulatory regions between B. recurrentis and B. duttonii

• Transcriptomic studies to assess glyA expression levels in both species under different growth conditions

• Heterologous expression of both B. recurrentis and B. duttonii glyA genes to compare enzyme kinetics and stability

The genomic context is particularly important considering that in B. duttonii and B. recurrentis, gene organization around the origin of replication includes clusters of intact genes (BDU_431-435, BRE_434-438) and the rrs operon (BDU_415-416, BDU_424, BRE_419-420, BRE_428) split by hpt, purA, and purB genes (BDU_418-420, BRE_422-424) .

What expression systems are optimal for producing recombinant B. recurrentis proteins?

Based on previous work with Borrelia proteins, E. coli expression systems have been successfully used. For example, the glpQ gene from B. recurrentis was cloned and expressed in E. coli for serological studies . For recombinant glyA expression, several considerations should be addressed:

• Codon optimization: B. recurrentis has a reduced genome with potential codon usage bias that differs from E. coli

• Purification strategy: Addition of affinity tags (histidine tags have been used successfully for other Borrelia proteins)

• Protein solubility: SHMT is typically a soluble cytoplasmic enzyme, but expression conditions may need optimization

• Activity assays: Spectrophotometric assays to measure the conversion of serine to glycine or vice versa

The study of other B. recurrentis proteins indicates that recombinant protein expression in E. coli can yield functionally active proteins suitable for both enzymatic and serological studies .

How does the infection mechanism of B. recurrentis relate to metabolic enzyme function?

B. recurrentis causes a relatively mild but persistent infection in immunocompromised mice (SCID and SCID BEIGE), but cannot proliferate in immunocompetent animals, suggesting host-specific adaptation . This specialization is reflected in its reduced genome compared to B. duttonii .

Research into how metabolic enzymes like SHMT contribute to this host adaptation could include:

• Comparative metabolomic studies between B. recurrentis and B. duttonii during infection

• Investigation of one-carbon metabolism under different host-mimicking conditions

• Analysis of how serine/glycine availability affects B. recurrentis persistence

The observation that B. recurrentis evolved from B. duttonii to become a primate-specific pathogen through genetic degeneration provides a unique opportunity to study how metabolic pathways adapt during host specialization .

What are the recommended protocols for glyA gene cloning from B. recurrentis?

Based on successful approaches with other B. recurrentis genes, the following protocol framework is recommended for glyA cloning:

• Genomic DNA extraction: Blood samples from LBRF patients or cultured B. recurrentis can serve as sources . Direct gene sequencing from patient samples has been demonstrated for genes like recA .

• PCR amplification: Design primers based on the known B. recurrentis genome sequence, potentially with restriction sites for directional cloning .

• Expression vector selection: Vectors with T7 or similar strong promoters and appropriate fusion tags for purification are recommended. Previous studies with B. recurrentis proteins have successfully used histidine tags .

• Transformation and screening: Standard E. coli strains (e.g., BL21(DE3)) are suitable hosts, with screening by colony PCR and confirmation by sequencing .

• Expression verification: Western blotting using anti-His antibodies or specific antibodies against SHMT if available .

What analytical methods are appropriate for characterizing recombinant B. recurrentis SHMT activity?

The enzymatic activity of recombinant SHMT can be assessed through several complementary approaches:

• Spectrophotometric assays: Measuring the conversion of serine to glycine by coupling to secondary reactions that produce detectable signals.

• Isotope labeling: Using 13C or 14C-labeled serine to track the transfer of one-carbon units in metabolic pathways.

• Crystallography: X-ray crystallography to determine the three-dimensional structure, particularly in comparison to SHMT from other bacterial species.

• Enzyme kinetics: Determining Km, Vmax, and other kinetic parameters under various conditions to assess the enzyme's catalytic efficiency.

• Inhibition studies: Testing known SHMT inhibitors to characterize the active site and potential differences from other bacterial SHMTs.

How might B. recurrentis SHMT be exploited for therapeutic development?

As a central metabolic enzyme, SHMT represents a potential therapeutic target. Research in this direction could explore:

• Structural analysis: Identifying unique structural features of B. recurrentis SHMT that could be targeted by selective inhibitors.

• Screening platforms: Developing high-throughput assays for identifying small molecule inhibitors specific to B. recurrentis SHMT.

• In vivo validation: Using the newly developed immunodeficient mouse models to test the efficacy of SHMT inhibitors in treating B. recurrentis infection .

• Combination approaches: Investigating synergistic effects between SHMT inhibitors and conventional antibiotics used for treating LBRF.

What implications does B. recurrentis genome reduction have for metabolic pathway research?

The genome reduction observed in B. recurrentis compared to B. duttonii raises intriguing questions about metabolic streamlining during host adaptation. Research approaches might include:

• Comparative metabolic modeling: Constructing in silico models of B. recurrentis and B. duttonii metabolism to identify critical differences.

• Essentiality studies: Determining which metabolic pathways are indispensable for B. recurrentis survival versus B. duttonii.

• Nutrient requirement analysis: Investigating how B. recurrentis has adapted to the specific nutrient environment provided by human hosts.

• Folate metabolism integration: Examining how SHMT functions within the context of a reduced genome and potentially simplified folate metabolism network.